SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-21-109686
Filing Date
2021-04-08
Accepted
2021-04-08 09:18:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 POS AM d150514dposam.htm POS AM 2105561
2 EX-23.1 d150514dex231.htm EX-23.1 1369
3 GRAPHIC g150514g21e41.jpg GRAPHIC 119453
4 GRAPHIC g150514g26d54.jpg GRAPHIC 179304
5 GRAPHIC g150514g30r39.jpg GRAPHIC 78009
6 GRAPHIC g150514g36q65.jpg GRAPHIC 51061
7 GRAPHIC g150514g38e46.jpg GRAPHIC 48393
8 GRAPHIC g150514g46n38.jpg GRAPHIC 122420
9 GRAPHIC g150514g54y57.jpg GRAPHIC 117225
10 GRAPHIC g150514g57t73.jpg GRAPHIC 55373
11 GRAPHIC g150514g91s41.jpg GRAPHIC 39871
  Complete submission text file 0001193125-21-109686.txt   3191935
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: POS AM | Act: 33 | File No.: 333-254021 | Film No.: 21813934
SIC: 2834 Pharmaceutical Preparations